Pristiq
NDC Package 43063-262-30
Package Information
Pristiq is desvenlafaxine is used to treat depression. Marketed by Pd-rx Pharmaceuticals, Inc., this product is identified by NDC 43063-262 and is authorized under FDA application NDA021992.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 43063 - Pd-rx Pharmaceuticals, Inc.
- 43063-262 - Pristiq
- 43063-262-30 - 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC
- 43063-262 - Pristiq
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 43063-262-30 identifies a specific commercial package of 30 tablet, extended release in 1 bottle, plastic of Pristiq Extended-release, labeled by Pd-rx Pharmaceuticals, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Pd-rx Pharmaceuticals, Inc. on May 01, 2008. The current certification is valid through August 16, 2022.
What are the primary indications for this medication?
Desvenlafaxine is used to treat depression. It may improve your mood, feelings of well-being, and energy level. Desvenlafaxine is known as a serotonin-norepinephrine reuptake inhibitor (SNRI). It works by helping to restore the balance of certain natural substances (serotonin and norepinephrine) in the brain.
How is this Pd-rx Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 43063026230. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.